Lau Associates’s Aceragen Inc ACGN Stock Holding History

Lau Associates’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$28K	Buy	904 +301	+50%	+$11.2K	0.01%	94
2019 Q3	$30K	Buy	+603	New	+$26.5K	0.02%	95
2018 Q4	–	Sell	-267	Closed	-$52K	–	102
2018 Q3	$52K	Buy	267 +70	+36%	+$10K	0.03%	90
2018 Q2	$35K	Buy	197 +21	+12%	+$4.9K	0.02%	76
2018 Q1	$37K	Buy	176 +43	+32%	+$11.8K	0.03%	77
2017 Q4	$38K	Hold	133	–	–	0.03%	77
2017 Q3	$40K	Buy	133 +28	+27%	+$7.32K	0.03%	75
2017 Q2	$24K	Buy	105 +22	+27%	+$5.75K	0.02%	75
2017 Q1	$28K	Buy	+83	New	+$20K	0.03%	76

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Lau Associates's ACGN Position: Q4 2019 in Review

Lau Associates increased its Aceragen Inc (ACGN) stake by 50% in Q4 2019, buying an estimated $11.2K and bringing the position to 904 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #94.

Lau Associates first reported a position in ACGN in Q1 2017 and has held it in 9 quarters since. The position peaked at $52K in Q3 2018. 50 funds tracked by Wall St. Rank hold ACGN as of Q4 2019.

Lau Associates held 904 shares of Aceragen Inc worth $28K as of Q4 2019.
Lau Associates bought 301 Aceragen Inc shares in Q4 2019, an estimated $11.2K.
Aceragen Inc made up 0.01% of Lau Associates's portfolio in Q4 2019, its #94 holding.
Lau Associates first reported a position in Aceragen Inc in Q1 2017 and has held it in 9 quarters since.
Lau Associates's Aceragen Inc position peaked at $52K in Q3 2018.
50 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.